Literature DB >> 19907488

Direct inhibition of the NOTCH transcription factor complex.

Raymond E Moellering1, Melanie Cornejo, Tina N Davis, Cristina Del Bianco, Jon C Aster, Stephen C Blacklow, Andrew L Kung, D Gary Gilliland, Gregory L Verdine, James E Bradner.   

Abstract

Direct inhibition of transcription factor complexes remains a central challenge in the discipline of ligand discovery. In general, these proteins lack surface involutions suitable for high-affinity binding by small molecules. Here we report the design of synthetic, cell-permeable, stabilized alpha-helical peptides that target a critical protein-protein interface in the NOTCH transactivation complex. We demonstrate that direct, high-affinity binding of the hydrocarbon-stapled peptide SAHM1 prevents assembly of the active transcriptional complex. Inappropriate NOTCH activation is directly implicated in the pathogenesis of several disease states, including T-cell acute lymphoblastic leukaemia (T-ALL). The treatment of leukaemic cells with SAHM1 results in genome-wide suppression of NOTCH-activated genes. Direct antagonism of the NOTCH transcriptional program causes potent, NOTCH-specific anti-proliferative effects in cultured cells and in a mouse model of NOTCH1-driven T-ALL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19907488      PMCID: PMC2951323          DOI: 10.1038/nature08543

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  47 in total

1.  Mastermind is a putative activator for Notch.

Authors:  A G Petcherski; J Kimble
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

Review 2.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

3.  MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors.

Authors:  L Wu; J C Aster; S C Blacklow; R Lake; S Artavanis-Tsakonas; J D Griffin
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

4.  Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain.

Authors:  H F Dovey; V John; J P Anderson; L Z Chen; P de Saint Andrieu; L Y Fang; S B Freedman; B Folmer; E Goldbach; E J Holsztynska; K L Hu; K L Johnson-Wood; S L Kennedy; D Kholodenko; J E Knops; L H Latimer; M Lee; Z Liao; I M Lieberburg; R N Motter; L C Mutter; J Nietz; K P Quinn; K L Sacchi; P A Seubert; G M Shopp; E D Thorsett; J S Tung; J Wu; S Yang; C T Yin; D B Schenk; P C May; L D Altstiel; M H Bender; L N Boggs; T C Britton; J C Clemens; D L Czilli; D K Dieckman-McGinty; J J Droste; K S Fuson; B D Gitter; P A Hyslop; E M Johnstone; W Y Li; S P Little; T E Mabry; F D Miller; J E Audia
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors.

Authors:  D Seiffert; J D Bradley; C M Rominger; D H Rominger; F Yang; J E Meredith; Q Wang; A H Roach; L A Thompson; S M Spitz; J N Higaki; S R Prakash; A P Combs; R A Copeland; S P Arneric; P R Hartig; D W Robertson; B Cordell; A M Stern; R E Olson; R Zaczek
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

6.  Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.

Authors:  J C Aster; L Xu; F G Karnell; V Patriub; J C Pui; W S Pear
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  Notch1 functions as a tumor suppressor in mouse skin.

Authors:  Michael Nicolas; Anita Wolfer; Kenneth Raj; J Alain Kummer; Pleasantine Mill; Mascha van Noort; Chi-chung Hui; Hans Clevers; G Paolo Dotto; Freddy Radtke
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

8.  Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex.

Authors:  Yunsun Nam; Andrew P Weng; Jon C Aster; Stephen C Blacklow
Journal:  J Biol Chem       Date:  2003-03-18       Impact factor: 5.157

9.  Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.

Authors:  Sudhir S Rao; Jennifer O'Neil; Cole D Liberator; James S Hardwick; Xudong Dai; Theresa Zhang; Edyta Tyminski; Jing Yuan; Nancy E Kohl; Victoria M Richon; Lex H T Van der Ploeg; Pamela M Carroll; Giulio F Draetta; A Thomas Look; Peter R Strack; Christopher G Winter
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

10.  Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.

Authors:  Andrew P Weng; Yunsun Nam; Michael S Wolfe; Warren S Pear; James D Griffin; Stephen C Blacklow; Jon C Aster
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

View more
  322 in total

1.  Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition.

Authors:  Michael M Madden; Avinash Muppidi; Zhenyu Li; Xiaolong Li; Jiandong Chen; Qing Lin
Journal:  Bioorg Med Chem Lett       Date:  2011-01-07       Impact factor: 2.823

2.  Evolving the use of peptides as components of biomaterials.

Authors:  Joel H Collier; Tatiana Segura
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

3.  Activation of the NOTCH1 pathway in chronic lymphocytic leukemia.

Authors:  Valentina Gianfelici
Journal:  Haematologica       Date:  2012-03       Impact factor: 9.941

4.  Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA.

Authors:  Keith K Khoo; Michael J Wilson; Brian J Smith; Min-Min Zhang; Joszef Gulyas; Doju Yoshikami; Jean E Rivier; Grzegorz Bulaj; Raymond S Norton
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

5.  Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Authors:  Todd D Ashworth; Warren S Pear; Mark Y Chiang; Stephen C Blacklow; Jérôme Mastio; Lanwei Xu; Michelle Kelliher; Philippe Kastner; Susan Chan; Jon C Aster
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

6.  Linking model systems to cancer therapeutics: the case of Mastermind.

Authors:  Barry Yedvobnick; Ken Moberg
Journal:  Dis Model Mech       Date:  2010-07-27       Impact factor: 5.758

7.  Helicity of short E-R/K peptides.

Authors:  Ruth F Sommese; Sivaraj Sivaramakrishnan; Robert L Baldwin; James A Spudich
Journal:  Protein Sci       Date:  2010-10       Impact factor: 6.725

8.  On-resin peptide macrocyclization using thiol-ene click chemistry.

Authors:  Alex A Aimetti; Richard K Shoemaker; Chien-Chi Lin; Kristi S Anseth
Journal:  Chem Commun (Camb)       Date:  2010-04-08       Impact factor: 6.222

9.  Controlled protein dimerization through hybrid coordination motifs.

Authors:  Robert J Radford; Phuong C Nguyen; Treffly B Ditri; Joshua S Figueroa; F Akif Tezcan
Journal:  Inorg Chem       Date:  2010-05-03       Impact factor: 5.165

10.  Hydrogen exchange-mass spectrometry measures stapled peptide conformational dynamics and predicts pharmacokinetic properties.

Authors:  Xiangguo Eric Shi; Thomas E Wales; Carl Elkin; Noriyuki Kawahata; John R Engen; D Allen Annis
Journal:  Anal Chem       Date:  2013-11-14       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.